Shawn Wallace

Shawn Wallace is a seasoned sales professional in the pharmaceutical industry with extensive experience in establishing strong relationships with healthcare providers. Currently serving as a Long Term Care Account Specialist at Neurocrine Biosciences since January 2022, Shawn previously held roles as an Executive Sales Representative at Novartis and Eli Lilly and Company, where responsibilities included managing patients with migraine disorders, rheumatoid arthritis, and psoriatic arthritis. Additionally, Shawn contributed to the launch of an antipsychotic medication for Parkinson’s Disease Psychosis at ACADIA Pharmaceuticals. With a foundation in Human Development & Family Studies from Texas Tech University, Shawn has consistently focused on improving patient outcomes through strategic partnerships with healthcare professionals across various therapeutic areas.